Zachary A. Weber

Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022

Mark W. Tenforde, Zachary A. Weber, Karthik Natarajan et al. · MMWR Morbidity and Mortality Weekly Report · 2022 · 109 citations · Full text

Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19–Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions — VISION Network, September 2022–April 2023

Ruth Link‐Gelles, Zachary A. Weber, Sarah E. Reese et al. · MMWR Morbidity and Mortality Weekly Report · 2023 · 96 citations · Full text

Immunodeficiencies, Immunology, Advisory Committee +21

Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance — VISION Network, 10 States, December 2021—August 2022

Amadea Britton, Peter J. Embí, Matthew E. Levy et al. · MMWR Morbidity and Mortality Weekly Report · 2022 · 85 citations · Full text

Interim Estimates of 2023–24 Seasonal Influenza Vaccine Effectiveness — United States

Aaron M. Frutos, Ashley M. Price, Elizabeth Harker et al. · MMWR Morbidity and Mortality Weekly Report · 2024 · 81 citations · Full text

Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years — VISION and IVY Networks, September 2023–January 2024

Jennifer DeCuir, Amanda B. Payne, Wesley H. Self et al. · MMWR Morbidity and Mortality Weekly Report · 2024 · 73 citations · Full text